Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05182931
Title A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) (I-FIRST)
Acronym I-FIRST
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Royal North Shore Hospital RECRUITING Sydney New South Wales Australia Details
Royal Brisbane and Women's Hospital RECRUITING Brisbane Queensland 4029 Australia Details
Royal Adelaide Hsopital RECRUITING Adelaide South Australia Australia Details
Eastern Health NOT_YET_RECRUITING Box Hill Victoria 3128 Australia Details
Monash Health RECRUITING Clayton Victoria 3168 Australia Details
Austin Health RECRUITING Heidelberg Victoria 3084 Australia Details
Alfred Hospital NOT_YET_RECRUITING Prahran Victoria Australia Details
Sir Charles Gairdner Hospital RECRUITING Perth Western Australia Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field